You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Cardiology and Radiology
Annually, 12-16% of device patients are likely to have an MRI ordered.1-4 Historically, less than 1% would have received a scan.1-4 Today, with our exclusive MRI portfolio, you can ensure safe MRI access for the most patients when MR conditions are met.
Medtronic has long been committed to providing cardiac device patients with access to the diagnostic and treatment benefits of MRI. Our portfolio of SureScan™ cardiac resynchronization therapy pacemaker (CRT-P), cardiac resynchronization therapy defibrillator (CRT-D), implantable cardioverter defibrillator (ICD), pacing, and insertable cardiac monitor (ICM) systems provides exactly that — safe, full body MRI access.
*EnRhythm MRI™ pacemaker is only labeled 1.5T MR Conditional.
*Pacemakers and ICDs: Patient cohorts were matched so both represent a group of patients with the same 1) Gender, 2) Age, 3) Major comorbidities
†CRT-Ds: Data from 2012 were used to project MRI utilization in the CRT patient cohort over 1 year; whereas the actual MRI utilization rate over 1 year was measured in the non-CRT cohort.
Data from 2010 MarketScan® Commercial and Medicare databases from Truven Health Analytics, Inc. were used to characterize non-pacemaker and pacemaker cohorts and utilization or radiology services. Cohorts were matched based on age, gender, and comorbidities.
Medtronic data on file 2015: ICD data from MarketScan® 2012 Commercial and Medicare Database, Truven Health Analytics.
Nazarian S, Reynolds MR, Ryan MP, et al. Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators. J Magn Reson Imaging. January 2016;43(1):115-127.
Medtronic data on file 2015: CRT data from MarketScan® 2012 Commercial and Medicare Database, Truven Health Analytics.
Ramza B, et al. Are There Cumulative Effects of Multiple MRI on MR-conditional Pacemakers? Presented at HRS, May 2014.
Gold MR, Sommer T, Schwitter J, et al. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study. J Am Coll Cardiol. June 23, 2015; 65(24):2581-2588.
Shenthar J, Milasinovic G, Al Fagih A, et al. MRI scanning in patients with new and existing CapSureFix Novus 5076 pacemaker leads: randomized trial results. Heart Rhythm. April 2015;12(4):759-765.
Gimbel JR, Bello D, Schmitt M, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. Heart Rhythm. May 2013;10(5):685-691.
Wilkoff BL, Bello D, Taborsky M, et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm. January 2011;8(1):65-73.